Optimizing	O
treatment	O
of	O
choroidal	B-Multi-tissue_structure
neovascularization	O
feeder	B-Multi-tissue_structure
vessels	I-Multi-tissue_structure
associated	O
with	O
age	O
-	O
related	O
macular	B-Tissue
degeneration	O
.	O

PURPOSE	O
:	O
To	O
optimize	O
the	O
method	O
of	O
treating	O
choroidal	B-Multi-tissue_structure
neovascularization	O
(	O
CNV	O
)	O
associated	O
with	O
age	O
-	O
related	O
macular	B-Tissue
degeneration	O
(	O
AMD	O
)	O
.	O

DESIGN	O
:	O
Experimental	O
study	O
and	O
interventional	O
case	O
series	O
.	O

METHODS	O
:	O
The	O
parameters	O
associated	O
with	O
locating	O
and	O
then	O
photocoagulating	O
CNV	O
feeder	B-Multi-tissue_structure
vessels	I-Multi-tissue_structure
were	O
identified	O
and	O
optimized	O
using	O
published	O
data	O
and	O
data	O
derived	O
from	O
modeling	O
the	O
choroidal	B-Multi-tissue_structure
vasculature	I-Multi-tissue_structure
.	O

Based	O
on	O
these	O
optimized	O
parameters	O
,	O
a	O
prototype	O
diagnostic	O
/	O
treatment	O
system	O
was	O
designed	O
that	O
captures	O
high	O
-	O
speed	O
indocyanine	O
green	O
(	O
ICG	O
)	O
angiogram	O
images	O
and	O
facilitates	O
analysis	O
of	O
the	O
images	O
by	O
enhancing	O
visualization	O
of	O
dye	O
movement	O
through	O
CNV	O
feeder	B-Multi-tissue_structure
vessels	I-Multi-tissue_structure
(	O
FVs	B-Multi-tissue_structure
)	O
.	O

The	O
system	O
also	O
permits	O
precise	O
aiming	O
and	O
delivery	O
of	O
810	O
-	O
nm	O
wavelength	O
photocoagulation	O
laser	O
energy	O
to	O
target	O
FVs	B-Multi-tissue_structure
on	O
a	O
real	O
-	O
time	O
ICG	O
angiogram	O
image	O
of	O
the	O
choroidal	B-Multi-tissue_structure
vasculature	I-Multi-tissue_structure
.	O

Target	O
FVs	B-Multi-tissue_structure
are	O
tracked	O
by	O
a	O
joy	O
-	O
stick	O
controlled	O
laser	O
aiming	O
beam	O
until	O
an	O
intravenously	B-Immaterial_anatomical_entity
-	O
injected	O
high	O
-	O
concentration	O
ICG	O
dye	O
bolus	O
is	O
observed	O
to	O
enter	O
the	O
target	O
vessel	B-Multi-tissue_structure
,	O
at	O
which	O
time	O
the	O
laser	O
is	O
fired	O
.	O

Proof	O
of	O
principle	O
of	O
the	O
combined	O
diagnosis	O
/	O
treatment	O
system	O
design	O
for	O
performing	O
dye	O
-	O
enhanced	O
photocoagulation	O
(	O
DEP	O
)	O
in	O
the	O
clinical	O
setting	O
and	O
determination	O
of	O
the	O
minimum	O
DEP	O
laser	O
energy	O
needed	O
to	O
close	O
CNV	O
FVs	B-Multi-tissue_structure
was	O
made	O
in	O
11	O
AMD	O
patients	O
requiring	O
treatment	O
of	O
CNV	O
,	O
but	O
for	O
whom	O
other	O
treatment	O
was	O
not	O
appropriate	O
.	O

RESULTS	O
:	O
Using	O
ICG	O
-	O
DEP	O
,	O
CNV	O
feeder	B-Multi-tissue_structure
vessels	I-Multi-tissue_structure
were	O
closed	O
with	O
single	O
pulse	O
laser	O
energy	O
,	O
delivering	O
as	O
little	O
as	O
0	O
.	O
6	O
to	O
1	O
.	O
8	O
J	O
of	O
energy	O
to	O
the	O
fundus	B-Multi-tissue_structure
,	O
producing	O
no	O
visible	O
change	O
in	O
the	O
fundus	B-Multi-tissue_structure
.	O

Successful	O
FV	B-Multi-tissue_structure
closure	O
was	O
usually	O
indicated	O
immediately	O
by	O
presence	O
of	O
incarcerated	O
ICG	O
dye	O
in	O
the	O
vessel	B-Multi-tissue_structure
adjacent	O
to	O
the	O
burn	O
site	B-Multi-tissue_structure
.	O

The	O
prototype	O
system	O
proved	O
relatively	O
easy	O
to	O
operate	O
.	O

After	O
acquiring	O
and	O
interpreting	O
diagnostic	O
angiograms	O
and	O
repositioning	O
a	O
patient	O
in	O
front	O
of	O
the	O
device	O
,	O
feeder	B-Multi-tissue_structure
vessel	I-Multi-tissue_structure
DEP	O
and	O
treatment	O
evaluation	O
required	O
15	O
to	O
20	O
minutes	O
.	O

CONCLUSIONS	O
:	O
Indocyanine	O
green	O
dye	O
-	O
enhanced	O
photocoagulation	O
of	O
CNV	O
feeder	B-Multi-tissue_structure
vessels	I-Multi-tissue_structure
,	O
facilitated	O
by	O
use	O
of	O
a	O
device	O
that	O
permits	O
real	O
-	O
time	O
visualization	O
of	O
the	O
choroidal	B-Multi-tissue_structure
circulation	O
while	O
aiming	O
the	O
treatment	O
laser	O
beam	O
,	O
appears	O
to	O
minimize	O
the	O
amount	O
of	O
energy	O
applied	O
to	O
the	O
fundus	B-Multi-tissue_structure
and	O
the	O
volume	O
of	O
fundus	B-Tissue
tissue	I-Tissue
affected	O
by	O
treatment	O
,	O
compared	O
with	O
other	O
treatment	O
modalities	O
.	O

The	O
combination	O
diagnosis	O
/	O
treatment	O
device	O
should	O
be	O
useful	O
in	O
optimizing	O
FV	B-Multi-tissue_structure
treatment	O
and	O
in	O
refining	O
and	O
evaluating	O
the	O
efficacy	O
of	O
DEP	O
in	O
future	O
clinical	O
trials	O
.	O

